Behind the Mystery: Understanding Blastic Plasmacytoid Dendritic Cell Neoplasm
September 4, 2019
Signs, Symptoms, and Treatments
Behind the Mystery takes a closer look at Blastic Plasmacytoid Dendritic Cell Neoplasm, a rare disease that is often misdiagnosed and affects at least 500 to 1,000 patients each year in the U.S.
Historically, the median survival from the time of diagnosis is anywhere from 8 to 14 months, and without treatment, BPDCN is oftentimes fatal.
The Balancing Act visited the Moffitt Cancer Center in Tampa, Florida to learn about BPDCN from oncologist Dr. Kendra Sweet. She shares the prevalence, who it can affect, and how it can present, as well as treatment options for patients.
Patient Dan Dan Beres was enjoying life with his wife when his diagnosis came out of nowhere. We will hear his story, as well as advice and guidance for patients diagnosed.
Mixing it up in sweet and savory ways: We’re featuring the world-famous, award-winning Angostura® aromatic bitters, orange bitters, and the newly introduced cocoa bitters.
Multiple sclerosis (MS) is an autoimmune condition where the immune system inappropriately attacks the brain and the spinal cord.
What women "auto" know about car insurance, plus living with and managing multiple sclerosis, and mixing it up with Angostura coca bitters.